Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2021 / Cilt: 31 - Sayı: 1

Autoimmune Hepatitis in Children

Çocuklarda Otoimmün Hepatit

Pages
1–8
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aimed to present the clinical findings, diagnosis and treatment methods of autoimmune hepatittis in children in the light of current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autoimmune hepatitis is characterized by inflammation in liver histology, circulating autoantibodies, and increased levels of immunglobulin G, in the absence of a known etiology.
📊
Key Findings & Data:In the last two decades, a a 6-fold increase in the incidence of autoimmune hepatitis has been reported thanks to update of diagnostic approaches and the increase in technical possibilities.
💡
Conclusion & Impact:In this review, we aimed to present the clinical findings, diagnosis and treatment methods of autoimmune hepatittis in children in the light of current literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Autoimmune hepatitis is characterized by inflammation in liver histology, circulating autoantibodies, and increased levels of immunglobulin G, in the absence of a known etiology. There are different clinical types described in children. Because of the presentation of autoimmune hepatitis with different clinical findings, establishment of diagnosis may be difficult. In the last two decades, a a 6-fold increase in the incidence of autoimmune hepatitis has been reported thanks to update of diagnostic approaches and the increase in technical possibilities. Autoimmune hepatitis should be considered in the differential diagnosis of any liver disease not caused by viral and metabolic factors. Its association with other clinical conditions such as autoimmune thyroiditis, vitiligo, collagen and connective tissue disorders is already known. Although autoimmune hepatitis is a treatable disorder, it may cause cirrhosis and fulminant hepatitis that need liver transplantation without treatment. In this review, we aimed to present the clinical findings, diagnosis and treatment methods of autoimmune hepatittis in children in the light of current literature.

Özet

Otoimmün hepatit, bilinen bir etiyoloji olmadan karaciğer histolojisinde inflamasyon, dolaşımdaki otoantikorlar ve immunglobulin G düzey yüksekliği ile karakterize kronik bir hastalıktır. Çocuklarda tanımlanmış farklı klinik tipleri vardır. Otoimmün hepatitin farklı klinik bulgular ile prezente olması nedeni ile tanı koymak zor olabilir. Son iki dekatta tanısal yaklaşımların güncellenmesi, teknik olasılıkların artması ile otoimmun hepatit sıklığında 6 kat artış bildirilmektedir. Viral ve metabolik nedenler dışındaki her karaciğer hastalığının ayırıcı tanısında otoimmun hepatit düşünülmelidir. Otoimmün tiroidit, vitiligo, kollajen ve bağ doku hastalıkları gibi diğer klinik durumlarla birlikteliği bilinmektedir. Otoimmün hepatit tedavi edilebilir bir hastalık olmakla birlikte, tedavisiz karaciğer nakli gerekebilen siroz ve fulminan hepatite neden olabilir. Bu derlemede, güncel literatür ışığında çocuklarda otoimmun hepatit klinik bulguları, tanı ve tedavi yöntemlerinin sunulması amaçlanmıştır.

🔖

Cite This Article

AKSOY, B., APPAK, Y. Ç., BARAN, M. (2021). Autoimmune Hepatitis in Children. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 31 - Sayı: 1, 1–8. https://ajindex.com/articles/345252

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr 2018
  2. 66(2):345-60. [CrossRef] 2. Sokollik C, McLin VA, Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. Juvenile autoimmune hepatitis: A comprehensive review. J Autoimmun. 2018
  3. [CrossRef] 3. Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis. 2002
  4. 22(4):353-64. [CrossRef] 4. Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018
  5. 18017. [CrossRef] 5. de Boer YS, Kosinski AS, Urban TJ, et al. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 2017
  6. 15(1):103-112.e2. [CrossRef] 6. Jimenez-Rivera C, Ling SC, Ahmed N, et al. Incidence and characteristics of autoimmune hepatitis. Pediatrics 2015
  7. e1237-48. [CrossRef] 7. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology. 2013
  8. 58 (4): 1392-1400. [CrossRef] 8. L. Grønbæk, H. Vilstrup, L. Pedersen, K. Christensen, P. Jepsen. Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study, J. Hepatol. 2018
  9. 69(4):873-877. [CrossRef] 9. Czaja, A. J. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018
  10. 48(4). [CrossRef] 10. Kerkar N, Chan A. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome. Clin Liver Dis. 2018
  11. 22(4): 689-702. [CrossRef] 11. Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani J. Autoimmune sclerosing cholangitis: Evidence and open questions. Autoimmun. 2018
  12. [CrossRef] 12. Kwon JH, Hanouneh IA, Allende D, et al. De Novo Autoimmune Hepatitis Following Liver Transplantation. Transplant Proc. 2018
  13. 50 (5): 1451-1456. [CrossRef] 13. Edmunds C, Ekong UD. Autoimmune liver disease post-liver transplantation: a summary and proposed areas for future research. Transplantation 2016
  14. [CrossRef] 14. Kerkar N, Yanni G. ‘De novo’ and ‘recurrent’ autoimmune hepatitis after liver transplantation: a comprehensive review. J Autoimmun 2016
  15. [CrossRef] 15. Elsürer R, Bayraktar Y.Primer sklerozan kolanjit. Hacettepe Tıp Dergisi 2004
  16. Pniewska A, Sobolewska-Pilarczyk M, Pawlowska M. Evalua